Edition:
India

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

102.72USD
23 May 2018
Change (% chg)

$0.68 (+0.67%)
Prev Close
$102.04
Open
$101.59
Day's High
$102.80
Day's Low
$101.59
Volume
115,651
Avg. Vol
213,918
52-wk High
$104.78
52-wk Low
$69.46

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $10,992.71
Shares Outstanding(Mil.): 142.30
Dividend: 0.35
Yield (%): 1.81

Financials

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

27 Apr 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

20 Apr 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

02 Apr 2018

BRIEF-ResMed Q2 Gaap Earnings Per Share $0.07

* ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018

23 Jan 2018

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

NZ's Fisher & Paykel sues Resmed in patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

Earnings vs. Estimates